by rss feed | Jul 27, 2025 | gene therapy, News Feeds, Sarepta, weekly reads
What is the deal with Sarepta lately? Things are spiraling. Before we dig into that, let’s give a RIP to Ozzy Osbourne, who had struggled with health issues. He was one of dozens of celebs to turn to unproven stem cells. Also, a heads up that student and stem...
by rss feed | Apr 16, 2023 | biotechs, Exondys 51, News Feeds, Sarepta, SRP-9001, weekly reads
The biotech Sarepta has had a complicated go of it with the FDA sometimes related to their Duchenne muscular dystrophy (DMD) gene therapy efforts. In late 2016 I wrote about how there was some controversy as the FDA approved the Sarepta drug eteplirsen (Exondys 51)...
